These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

497 related items for PubMed ID: 25093620

  • 1. Relationship between serum sclerostin, bone metabolism markers, and bone mineral density in maintenance hemodialysis patients.
    Ishimura E, Okuno S, Ichii M, Norimine K, Yamakawa T, Shoji S, Nishizawa Y, Inaba M.
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4315-20. PubMed ID: 25093620
    [Abstract] [Full Text] [Related]

  • 2. Paediatric reference values for the C-terminal fragment of fibroblast-growth factor-23, sclerostin, bone-specific alkaline phosphatase and isoform 5b of tartrate-resistant acid phosphatase.
    Fischer DC, Mischek A, Wolf S, Rahn A, Salweski B, Kundt G, Haffner D.
    Ann Clin Biochem; 2012 Nov; 49(Pt 6):546-53. PubMed ID: 22984195
    [Abstract] [Full Text] [Related]

  • 3. Serum adiponectin and bone mineral density in male hemodialysis patients.
    Okuno S, Ishimura E, Norimine K, Tsuboniwa N, Kagitani S, Yamakawa K, Yamakawa T, Sato KK, Hayashi T, Shoji S, Nishizawa Y, Inaba M.
    Osteoporos Int; 2012 Jul; 23(7):2027-35. PubMed ID: 21927917
    [Abstract] [Full Text] [Related]

  • 4. Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients.
    Małyszko J, Małyszko JS, Pawlak K, Wołczyński S, Myśliwiec M.
    Adv Med Sci; 2006 Jul; 51():69-72. PubMed ID: 17357281
    [Abstract] [Full Text] [Related]

  • 5. Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis.
    Malluche HH, Davenport DL, Cantor T, Monier-Faugere MC.
    Clin J Am Soc Nephrol; 2014 Jul; 9(7):1254-62. PubMed ID: 24948144
    [Abstract] [Full Text] [Related]

  • 6. Relationship between biochemical markers and radial cortical bone changes in hemodialysis patients.
    Fujimori A, Okada S, Sakai M, Tome K, Fukagawa M.
    Nephron Clin Pract; 2011 Jul; 118(4):c375-9. PubMed ID: 21325869
    [Abstract] [Full Text] [Related]

  • 7. Risk factors for diminished bone mineral density among male hemodialysis patients--a cross-sectional study.
    Mirfakhraee S, Sakhaee K, Zerwekh J, Adams-Huet B, Gruntmanis U.
    Arch Osteoporos; 2012 Jul; 7():283-90. PubMed ID: 23152064
    [Abstract] [Full Text] [Related]

  • 8. Serum sclerostin: the missing link in the bone-vessel cross-talk in hemodialysis patients?
    Pelletier S, Confavreux CB, Haesebaert J, Guebre-Egziabher F, Bacchetta J, Carlier MC, Chardon L, Laville M, Chapurlat R, London GM, Lafage-Proust MH, Fouque D.
    Osteoporos Int; 2015 Aug; 26(8):2165-74. PubMed ID: 25910747
    [Abstract] [Full Text] [Related]

  • 9. Markers of bone metabolism are affected by renal function and growth hormone therapy in children with chronic kidney disease.
    Doyon A, Fischer DC, Bayazit AK, Canpolat N, Duzova A, Sözeri B, Bacchetta J, Balat A, Büscher A, Candan C, Cakar N, Donmez O, Dusek J, Heckel M, Klaus G, Mir S, Özcelik G, Sever L, Shroff R, Vidal E, Wühl E, Gondan M, Melk A, Querfeld U, Haffner D, Schaefer F, 4C Study Consortium.
    PLoS One; 2015 Aug; 10(2):e0113482. PubMed ID: 25659076
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Association of circulating sclerostin with bone mineral mass, microstructure, and turnover biochemical markers in healthy elderly men and women.
    Durosier C, van Lierop A, Ferrari S, Chevalley T, Papapoulos S, Rizzoli R.
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3873-83. PubMed ID: 23864703
    [Abstract] [Full Text] [Related]

  • 12. Bone turnover markers predict changes in bone mineral density after parathyroidectomy in patients with renal hyperparathyroidism.
    Lu KC, Ma WY, Yu JC, Wu CC, Chu P.
    Clin Endocrinol (Oxf); 2012 May; 76(5):634-42. PubMed ID: 22007930
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patients.
    Okuno S, Inaba M, Kitatani K, Ishimura E, Yamakawa T, Nishizawa Y.
    Osteoporos Int; 2005 May; 16(5):501-9. PubMed ID: 15309383
    [Abstract] [Full Text] [Related]

  • 15. The relationship between intact PTH and biointact PTH (1-84) with bone and mineral metabolism in pre-dialysis chronic kidney disease (CKD).
    O'Flaherty D, Sankaralingam A, Scully P, Manghat P, Goldsmith D, Hampson G.
    Clin Biochem; 2013 Oct; 46(15):1405-9. PubMed ID: 23830844
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The clinical utility of serum tartrate-resistant acid phosphatase 5b in the assessment of bone resorption in patients on peritoneal dialysis.
    Yamada S, Tsuruya K, Yoshida H, Taniguchi M, Haruyama N, Tanaka S, Eriguchi M, Nakano T, Kitazono T.
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):844-51. PubMed ID: 23078546
    [Abstract] [Full Text] [Related]

  • 18. Usefulness of bone resorption markers in hemodialysis patients.
    Hamano T, Tomida K, Mikami S, Matsui I, Fujii N, Imai E, Rakugi H, Isaka Y.
    Bone; 2009 Jul; 45 Suppl 1():S19-25. PubMed ID: 19332165
    [Abstract] [Full Text] [Related]

  • 19. Serum levels of TRAP5b, a new bone resorption marker unaffected by renal dysfunction, as a useful marker of cortical bone loss in hemodialysis patients.
    Shidara K, Inaba M, Okuno S, Yamada S, Kumeda Y, Imanishi Y, Yamakawa T, Ishimura E, Nishizawa Y.
    Calcif Tissue Int; 2008 Apr; 82(4):278-87. PubMed ID: 18421493
    [Abstract] [Full Text] [Related]

  • 20. Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients.
    Okuno S, Ishimura E, Tsuboniwa N, Norimine K, Yamakawa K, Yamakawa T, Shoji S, Mori K, Nishizawa Y, Inaba M.
    Osteoporos Int; 2013 Feb; 24(2):605-12. PubMed ID: 22581293
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.